Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, CA
Clinical Trial Details
Research Study Summary
Alzheimers? Be a Part of Research.
This study is for participants that have been diagnosed with a mild to moderate form of Alzheimer's disease (AD). This research involves an experimental study drug known as LY2062430. The primary objective of this study is to test whether LY2062430 will slow the rate of mental (thinking and remembering) decline of Alzheimer's disease as compared with placebo (a substance that looks like the study drug, but has no medicine).
Qualified Participants Must: Be diagnosed with a mild to moderate form of Alzheimer's disease; Have a reliable caregiver who is in frequent contact with you; Have good veins
Qualified Participants Will Receive: $50 per completed study visit.
To Learn more
Both Male and Female
Date Last Changed:
July 24, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these